Federal contract award
HT942524C0010
DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS" PLEASE NOTE CLR IS NOT AN ABBREVIATION.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.3M |
| Current contract value | $1.3M |
| Potential contract value / ceiling | $1.3M |
| Start date | Jan 5, 2024 |
| Current end date | May 4, 2027 |
| Potential end date | May 4, 2027 |
| Latest award activity | Jun 11, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 11, 2026 | P00003 | $0 | AGITUBE (NOW CLR): FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS |
| Sep 29, 2025 | P00002 | $0 | AGITUBE (NOW CLR): FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS |
| Jun 27, 2025 | P00001 | $0 | DHA SEQUENTIAL PHASE II TITLED: AGITUBE (NOW CLR), FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS |
| Dec 12, 2023 | 0 | $1.3M | DHA SBIR SEQUENTIAL MEDICAL RESEARCH AND DEVELOPMENT PHASE II CONTRACT TITLED: AGITUBE (NOW CLR),"FURTHER STUDIES TO REFINE DEVICE USE FOR THE MANAGEMENT OF HEMOTHORAX AND OTHER PLEURAL COLLECTIONS" PLEASE NOTE CLR IS NOT AN ABBREVIATION. |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-05-04 (184 days from calculation)
- +35 points
- 99 historical awards in this buyer and category group
- +15 points
- 4 recorded award transactions
- +10 points
- Latest award action: 2026-06-11
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.